DEF 14AThe Ballot
Entrada Therapeutics, Inc. files DEF 14A
Filed Apr 19, 2022 · 4y ago · Accession 0001104659-22-047338
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Entrada Therapeutics, Inc.
- Ticker
- TRDA
- CIK
- 1689375
- Form type
- DEF 14A
- Filing date
- Apr 19, 2022
- Report date
- Jun 2, 2022
- Document
- tm2212715-1_def14a.htm
- Size
- 1.8 MB